Use of polyanionic and polyanionically-derivatised natural polysaccharides for inhibiting alkaline phosphatase
US6514950B1 · kind B1 · utility
4Cited by
5References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 19, 2000 |
| Grant date | Feb 4, 2003 |
| Priority date | — |
| Expiry date | Jun 19, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/782
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A description is given of the use of polyanionic and polyanionically-derivatised natural polysaccharides or non-derivatised natural polysaccharides for inhibiting alkaline phosphatase and of oral compositions for preventing bacterial plaque, which comprises (a) 0 to 10% by weight of at least one linear molecularly dehydrated polyphosphate salt, and (b) 0.0001 to 5% by weight of a polyanionic or polyanionically-derivatised natural polysaccharide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.